Geneva researchers find old drug helps fight antibiotic resistance
Researchers from the University of Geneva have found that an anti-herpes drug discovered more than 50 years ago can make it easier for the immune system to attack a common and deadly bacteria.
This content was published on
2 minutes
swissinfo.ch/jdp
Português
pt
Pesquisadores de Genebra descobrem que medicamento antigo pode ajudar a combater a resistência aos antibióticos
The bacteria Klebsiella pneumoniae is very common in hospitals, causing many respiratory, intestinal and urinary tract infections. Like many other bacteria, it’s become increasingly resistant to today’s antibiotics. As a result, some strains have been fatal for 40% to 50% of people infected.
A team from the University of Geneva (UNIGE) has now found that edoxudine, an anti-herpes molecule discovered in the 1960s, weakens the protective surface of Klebsiella bacteria and makes them easier for immune cells to attack them. These resultsExternal link were published in the journal PLOS ONE.
“Since the 1930s, medicine has relied on antibiotics to get rid of pathogenic bacteria,” explained Pierre Cosson, professor in the Department of Cell Physiology and Metabolism at the UNIGE Faculty of Medicine, who led the research. “But other approaches are possible, among which trying to weaken the bacteria’s defense system so that they can no longer escape the immune system.”
He adds that this this approach is particularly promising because the strength of the Klebsiella pneumoniae stems largely from its ability to evade attacks from immune cells.
To determine whether the drug had worked to weaken the bacteria’s defenses, the UNIGE scientists used an experimental model based on the amoeba Dictyostelium. This single-cell organism feeds on bacteria by capturing and ingesting them, using the same mechanisms that immune cells use to kill pathogens. “We genetically modified this amoeba so that it could tell us whether the bacteria it encountered were virulent or not,” said Cosson.
More
More
Looming bacterial pandemic triggers debate over how to pay for new antibiotics
This content was published on
Few big pharmaceutical companies have a stake in new antibiotics research. Financial incentives could help, but they are controversial.
This made it possible test thousands of existing drugs and identify those that reduced the bacteria’s strength. The anti-herpes drug edoxudine is interesting in the way it alters the surface layer that protects the bacteria from the external environment.
Unlike an antibiotic, this drug doesn’t kill the bacteria, which “limits the risk of developing resistance, a major advantage of such an anti-virulence strategy,” said Cosson.
The treatment’s effectiveness hasn’t been confirmed in humans but the researchers say the results thus far are encouraging.
Switzerland abstains from vote on Palestinian bid for full UN membership
This content was published on
On Friday, Switzerland abstained from the vote at the General Assembly on granting the Palestinians new rights at the United Nations (UN).
Protein in abdominal fat could help shape obesity treatment
This content was published on
The study analysed fat cells from different locations in the body, and found that those in the abdomen have unique properties.
North African asylum claims fall after rapid Swiss processing
This content was published on
The accelerated procedure, now out of its test phase, has resulted in a significant drop in applications from North African countries.
This content was published on
The artist's song "The Code" focuses on their journey as a nonbinary individual. It is one of the favourites to win this year's contest.
Swiss climate activists block vehicles near Gotthard tunnel
This content was published on
Around ten climate activists briefly blocked the A2 motorway near the northern entrance of the Gotthard tunnel on Thursday.
This content was published on
As money is poured into the search for a silver bullet to Covid-19, some experts warn that the pandemic could also worsen the antibiotics crisis.
This content was published on
Swiss federal authorities have launched a public information campaign to raise awareness of the proper use of antibiotic medicine.
This content was published on
The amount of antibiotics sold for treatment of animals continued to fall last year, amid rising awareness of antibiotic resistance.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.